Cellectis SA, a biotechnology company dedicated to rational genome engineering and specialized in DNA recombination and reprogramming in living organisms, announced today that the company has signed a license under the Meganuclease Recombination System with BASF Plant Science. The agreement is following the evaluation and use of Cellectis’ proprietary Meganuclease for the deletion/excision of nucleotide sequences, such as marker genes, in plants for agricultural and nutritional applications. Financial terms and conditions of the agreement were not disclosed.
